International Clinical Trial: A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07359846) titled 'A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)' on Jan. 21.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Generate Biomedicines

Condition: Severe Asthma

Intervention: Drug: GB-0895

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: January 2026

Target Sample Size: 786

To know more, visit https://clinicaltrials.gov/study/NCT07359846

Disclaimer:...